Saki joined the National Drug and Alcohol Centre (NDARC) in 2018. She is currently working with the CESSATE Study Research Team, a study evaluating the cost-effectiveness of two smoking cessation products, Desmoxan and Champix. Previously, Saki’s research has focused on Assessing Physical and Mental Health Effects of Working Condition on Female Ready-Made Garment (RMG) workers in Bangladesh. Saki's thesis (Hons, 2017) examined whether parental monitoring reduces adolescents' smoking and substance use in Bangladesh.
MPH, BSc (Public Health Studies)
Talukder SR; Lappin JM; Boland V; McRobbie H; Courtney RJ, 2021, 'Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders', TOBACCO CONTROL, http://dx.doi.org/10.1136/tobaccocontrol-2021-056843